Listed proteins shown were identified from triplicate experiments. Average spectral counts (SpC) and standard deviations correspondong to the indicated protein that was detected in triplicate mass specs where myc-TRF1 was used as the bait.
EXPERIMENTAL PROCEDURES

Cell lines and reagents
U2OS, Saos2, VA13, SW26, SW39 and HeLa LT were obtained from ATCC and cultured in Glutamax-DMEM (Life Technologies) supplemented with 10% bovine growth serum. Cells were cultured at low oxygen conditions of 3% O 2 and 7.5% CO 2 .
Aphidicolin (Sigma-Aldrich) was used at 0.2-0.3µM in culture medium for 12-24hrs as indicated. Hydroxyurea (Sigma-Aldrich) was used at 0.1-1mM in culture medium for the indicated durations. To generate a myc-BirA-TRF1 fusion protein, TRF1 was excised from pLPC-TRF1 using BamHI-EcoRI restriction sites and cloned using the same sites in pLPC-mycBirA plasmid. All other plasmids were obtained as follows: pLPC-myc-BirA plasmid was a gift from Dr. Eros Lazzerini (Scripps La Jolla, CA). pEGFP-NLS-Polη, pcDNA3.1-FLAG-Polη WT, ΔUBZ and ΔPIP were gifts from Dr. Alan Lehmann (University of Sussex, UK) and described in (Bienko et al., 2010) . pEGFP-Polκ was a gift from T Huang (NYU) and described in (Jones et al., 2012) . pEGFP-RAD18 was a gift from Dr.
Antibodies and
Cyrus Vaziri (University of North Carolina, NC) and described in (Durando et al., 2013) .
pLPC-myc and pLPC-FLAG-TRF1 were a gift from Dr. Jan Karlseder (Salk Institute, CA). WT and nuclease dead (D450A) TRF1-FokI plasmids were a gift from Roger Proximity-dependent biotinylation and streptavidin capture of biotinylated proteins. U2OS and HeLa cell stably expressing myc-BirA alone or myc-BirA-TRF1
were generated by retroviral infection with particles generated from amphotrophic 293T viral packaging cell lines. Infected cells were selected using puromycin (2mg/ml) for 5-7 days and stable protein expression was validated by western blot and immunofluorescence. Proximity-dependent biotinylation and streptavidin capture of biotinylated proteins was performed as described in (Roux et al., 2012) with minor modifications. Briefly, cells (6 x 10 7 ) were incubated for 24hrs in complete media supplemented with 50µM biotin (Sigma-Aldrich). Cells were harvest and washed in PBS prior to lysis in 0.2% NP40 buffer to remove cytoplasmic proteins. Cell pellet was lysed in buffer SDS and sonicated to extract nuclear proteins, and finally heated at 98°C for 5mins to denature proteins. Protein samples were incubated with magnetic streptavidin beads (Millipore) overnight at 4°C on a rotary shaker. Next day, beads were washed and finally eluted in 50mM Tris (pH 7.4), 50mM NaCl and 2% SDS together with boiling at 98°C for 5mins.
Mass Spectrometry and Bio-ID of TRF1 associated proteins. Immuno-precipitated samples were separated ~1.5cm on a 10% Bis-Tris Novex mini-gel (Invitrogen) using the MES buffer system. The gel was stained with coomassie and each lane was excised into ten equally sized segments. Gel pieces were processed using a robot (ProGest, DigiLab) as follow: First washes were with 25mM ammonium bicarbonate followed by acetonitrile. Then, reduced with 10mM dithiothreitol at 60°C followed by alkylation with 50mM iodoacetamide at RT. Samples were digested with trypsin (Promega) at 37°C for 4hrs, and then quenched with formic acid. Samples supernatants were analyzed directly without further processing using a nano LC/MS/MS with a Waters NanoAcquity HPLC system interfaced to a ThermoFisher Q Exactive. Peptides were loaded on a trapping column and eluted over a 75mm analytical column at 350nL/min; both columns were siRNA transfections. For siRNA knockdown we used the On-Target Plus (OTP) siRNA smartpools from Dharmacon (GE). We also used a single siRNA targeting the 3'UTR of Polη mRNA. The sequence of this siRNA oligo is; 5′-GCAATGAGGGCCTTGAACA-3
and was synthesized and purchased from Dharmacon (GE). Briefly, ~200,000 and ~700,000 cells were seeded per well of a 6-well plate and 10cm dish containing growth medium without antibiotics, respectively. ~2hrs later cells were transfected. siRNAs and Dharmafect were diluted in OptiMEM (Life Technologies). A working siRNA concentration of 50nM was used. We used 2.5ml and 5ml Dharmafect #1 per well and 10cm plate, respectively. Transfection medium was replaced with complete culture media 24hrs later or cells were split for desired application and harvested at 72hrs post transfection, unless otherwise indicated.
Direct Immunofluorescence. All immunofluorescence was performed as described in 
Analysis of DNA synthesis on metaphase chromosomes.
Telomeres with delayed replication were quantified using an in situ 5-ethynyl-2'-deoxyuridine (EdU) incorporation assay combined with telomeric FISH. U2OS cells were seed on coverslip and siRNA transfected. 24hrs later, cells were treated with 0.3µM aphidicolin for 24hrs. Cells were incubated with 10µM EdU for 40mins and immediately fixed in PBS containing 4% PFA for 20mins and then permeabilized in PBS-0.5% Triton X-100 for 30mins. EdU was detected by click reaction using the Click-iT EdU-Alexa 488
Imaging kit (Life Technologies), according to the manufacturers' instructions. EdU staining was fixed with 4% PFA for 10mins and subsequently FISH was performed as described above with Cy3-(CCCTAA) n PNA probe. Images were acquired using a LSM 780 (Zeiss) confocal microscope with a 63X Plan-ApoChromat objective (1.4 oil) and argon laser at 488 nm, DPSS laser at 561nm, and helium laser at 633nm.
FokI mediated induction of telomeric DSBs.
U2OS cells were transfected with siRNA as indicated. 48hrs later, the same cells were transfected with mCherry-TRF1-FokI-ER-DD WT or the inactive FokI mutant D450A.
FokI transgenes were induced with 4-OHT (2 mM) and Shield1 ligand (0.5mM) as previously described (Cho et al., 2014) . Cells were processed for immunofluorescence using PML antibody as described above. APBs (mCherry-TRF1 and PML colocalizations) were quantified in triplicate using NIS-Elements Advanced Research software (Nikon) as #APBs per cell.
C-Circle Assay. The protocol for C-circle amplification was employed as (O'Sullivan et al., 2014) . Briefly, genomic DNA was purified, digested with AluI and MboI and cleaned up by phenol-chloroform extraction and precipitation. DNA was diluted in ultraclean water and concentrations were exhaustively measured to the indicated quantity (generally, 30, 15, 7.5ng) using a Nanodrop (ThermoFisher). Samples (10µl) were combined with 10µl BSA (NEB; 0.2 mg/ml), 0.1% Tween, 0.2mM each dATP, dGTP, dTTP and 1 × Φ29 Buffer (NEB) in the presence or absence of 7.5U ΦDNA polymerase (NEB). Samples were incubated at 30°C for 8hrs and then at 65°C for 20mins. Reaction products were diluted to 100µl with 2 × SSC and dot-blotted onto a 2 × SSC-soaked nylon membrane. DNA was UV cross-linked onto the membrane and hybridized with a P 32 end-labelled (CCCTAA) 4 oligo probe to detect C-circle amplification products. All blots were washed, exposed to PhosphoImager screens, scanned and quantified using a Typhoon 9400 PhosphoImager (Amersham/GE Healthcare). In all reactions, when Φ29
was omitted as a negative control, U2OS DNA was used.
T-Circle Assay. The protocol for T-circle amplification was performed as in (Zellinger et al., 2007) . Genomic DNA was prepared as above. Then DNA was denatured at 96°C for 5 mins and annealed to 50pmol of the telomere-specific primer (CCCTAA) 4 for 30-60mins at RT in a buffer containing 200mM Tris-HCl pH 7.5, 200mM KCl and 1mM
EDTA in a total volume of 20ml. Half (10ml) of the annealed reaction was incubated at 30°C for 12hrs in the presence of dNTPs (0.2mM each), BSA (NEB; 0.2mg/ml), 1×Φ29
buffer (NEB) and 7.5U Φ29 DNA polymerase (NEB) in a total volume of 20ml, and the remaining half was incubated under identical conditions with one exception; the Φ29 DNA polymerase was excluded from the reaction. Both sets of reactions that did or did not include Φ29 were further incubated at 65 °C for 20mins. The samples were then electrophoresed on 0.5% agarose gels at 120V for 1hr then 38-40V overnight in 0.5×TBE buffer in the presence of ethidium bromide. After electrophoresis the gels were dried at 50°C, denatured and hybridized P 32 end-labeled (TTAGGG) 4 oligo probe. All blots were washed and exposed to PhosphoImager screens.
Telomere chromatin immunoprecipitation (ChIP). ChIP was performed as described in (O'Sullivan et al., 2014) .
Flow Cytometry. Cells to be used for flow cytometry were fixed in 70% EtOH and stained directly with propidium iodide (Life Technology) containing RNase A (100ng/ml). Cell cycle profiles were analyzed using BD Accuri C6.
D-loop assay.
Proteins. Recombinant human DNA polymerase η was purchased from Enzymax (Lexington, KY). Recombinant human Polδ (four subunits) was purified as described previously (Xie et al., 2002) . Recombinant PCNA and RFC were purified from Escherichia coli overproduction strains as described (Ayyagari et al., 2003) .
Recombinant RecA protein was purchased from New England Biolabs (Ipswich, MA).
DNA substrates. All unmodified oligonucleotides were purchased from Integrated DNA Technologies (Coralville, IA) and were purified by PAGE or HPLC by the manufacturer.
Oligonucleotides were 5́ end labelled using [γ-32 P] ATP (3000Ci/mmol) (Perkin Elmer, Waltham, MA) with OptiKinase (Affymetrix, Santa Clara, CA) following the manufacturer's instructions. The plasmid used for preparing the 120-bp telomeric and non-telomeric D-loops was as described in (Hile et al., 2000) , and was purified by two rounds of ethidium bromide saturated CsCl equilibrium gradient ultracentrifugation substrates were constructed as described previously (Bachrati and Hickson, 2006) .
Briefly, 5́ end radiolabeled invading strand oligonucleotide (5.0 pmol) was incubated in
RecA buffer (500mM Tris, pH 7.5, 150mM MgCl 2 , 10mM DTT, 1 mg/mL BSA) with
RecA enzyme (0.2 µg/µL) in the presence of ATP (3.0 mM), Phosphocreatine (28.6mM) and Creatine Phosphokinase (14.3U/mL) (Sigma Aldrich, St. Louis, MO) for 5mins at 37°C. 10 µg of the supercoiled plasmid was then added and incubated for another 3mins at 37°C. The reaction was terminated using stop buffer containing 10 mg/mL Proteinase K (New England Biolabs, Ipswich, MA) and 3.0% SDS (Thermo Fisher, Waltham MA)
followed by incubation for 30mins at 37°C. The D-loop constructs were PAGE purified using 4.5% (37.5:1) polyacrylamide gels at 200V for 2hrs. The D-loop substrates were visualized by phosphorimager analysis, excised, and subjected to electro-elution using dialysis D-tubes (Novagen, Madison, WI) in 1xTBE for 3 hrs at 4°C and 120V. Samples were then concentrated using micron-30 columns (Amicon) and exchanged into dialysis buffer (10 mM Tris, pH 7.5, 10 mM MgCl 2 ). Product purity and yield were determined by analysis on 4-20% native polyacrylamide gel, followed by quantification using Typhoon phosphorimager and ImageQuant software (GE Healthcare, Piscataway, NJ). 100°C for 10mins and snap cooled in ice before loading on a 10% denaturing polyacrylamide gel for 3hrs under constant current of 38W. The gel was exposed overnight and visualized using Typhoon phosphorimager. Unused primer was quantified using ImageQuant software and background corrected using the no enzyme control reactions. To analyze the extent of DNA synthesis, the amount of radioactivity in bands for products was divided by the total amount of radioactivity in the lane.
D-loop extension
